GC
Gavin Clark-Gartner Evercore ISI Group Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Mirum Pharmaceuticals
MIRM
$3.82B
| $76.06 | $89 |
17%
upside
| Outperform |
8 Aug ‘25
1 month ago |
|
2
AbbVie
ABBV
$375B
| $212.56 | $207 |
3%
downside
| Outperform |
1 Aug ‘25
1 month ago |
|
3
Jasper Therapeutics
JSPR
$44.2M
| $2.72 | $20 |
635%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
4
ProQR Therapeutics
PRQR
$258M
| $2.45 | $5 |
104%
upside
| Outperform |
29 Apr ‘25
4 months ago |
|
5
MindMed
MNMD
$702M
| $9.22 | $23 |
149%
upside
| Outperform |
28 Jan ‘25
7 months ago |
|
6
Cabaletta Bio
CABA
$155M
| $1.70 | $6 |
253%
upside
| In-Line |
20 Dec ‘24
8 months ago |
|
7
argenx
ARGX
$45.9B
| $750.78 | $706 |
6%
downside
| Outperform |
21 Nov ‘24
9 months ago |
|
8
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $170 |
809%
upside
| Outperform |
7 Nov ‘24
10 months ago |
|
9
Foghorn Therapeutics
FHTX
$326M
| $5.77 | $20 |
247%
upside
| Outperform |
19 Aug ‘24
1 year ago |
|
10
Krystal Biotech
KRYS
$4.35B
| $150.27 | $206 |
37%
upside
| Outperform |
12 Aug ‘24
1 year ago |
|
11
Aclaris Therapeutics
ACRS
$227M
| $2.10 | $22 |
948%
upside
| Outperform |
3 Oct ‘23
1 year ago |
|
12
C4 Therapeutics
CCCC
$194M
| $2.72 | $10 |
268%
upside
| Outperform |
30 May ‘23
2 years ago |
|